{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:56:18Z","timestamp":1767135378488,"version":"build-2238731810"},"publisher-location":"Chichester, UK","reference-count":130,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd007253.pub2","type":"reference-entry","created":{"date-parts":[[2010,6,15]],"date-time":"2010-06-15T11:58:21Z","timestamp":1276603101000},"source":"Crossref","is-referenced-by-count":48,"title":["Interventions for smoking cessation and reduction in individuals with schizophrenia"],"prefix":"10.1002","author":[{"given":"Daniel T","family":"Tsoi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamta","family":"Porwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela C","family":"Webster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,6,15]]},"reference":[{"key":"10.1002\/14651858.CD007253.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1176\/ajp.2006.163.11.1934","article-title":"A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder","volume":"163","author":"Baker","year":"2006","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007253.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.psychres.2006.05.021","article-title":"Characteristics of smokers with a psychotic disorder and implications for smoking interventions","volume":"150","author":"Baker","year":"2007","journal-title":"Psychiatry Research"},{"issue":"4","key":"10.1002\/14651858.CD007253.pub2-BIB3|cit3","first-page":"681","article-title":"Intervention for tobacco dependence among people with a psychotic illness: RCT with one year outcome","volume":"7","author":"Richmond","year":"2005","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1002\/14651858.CD007253.pub2-BIB4|cit4","series-title":"Conference Abstract of Society for Research on Nicotine and Tobacco 9th Annual Meeting: New Orleans, Louisiana, USA","article-title":"Increased smoking cessation and reduction: Two years following a smoking cessation trial in patients with schizophrenia","author":"Evins","year":"2003"},{"issue":"4","key":"10.1002\/14651858.CD007253.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/14622200110073920","article-title":"A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia","volume":"3","author":"Evins","year":"2001","journal-title":"Nicotine & Tobacco Research"},{"issue":"3","key":"10.1002\/14651858.CD007253.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4088\/JCP.v65n0304","article-title":"Two-year follow-up of a smoking cessation trial in patients with schizophrenia: increased rates of smoking cessation and reduction","volume":"65","author":"Evins","year":"2004","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD007253.pub2-BIB7|cit7","series-title":"Conference abstract of Society for Research on Nicotine and Tobacco 6th Annual Meeting: Arlington, Virginia, USA","article-title":"Reduction In tobacco use in schizophrenia with bupropion SR and Cognitive Behavioral Therapy","author":"Evins","year":"2000"},{"issue":"3","key":"10.1002\/14651858.CD007253.pub2-BIB8|cit8","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.jcp.0000162802.54076.18","article-title":"A double-blind placebo-controlled trial of bupropion Sustained-Release for smoking cessation in schizophrenia","volume":"25","author":"Evins","year":"2005","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"9","key":"10.1002\/14651858.CD007253.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.4088\/JCP.v66n0915","article-title":"Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia","volume":"66","author":"Evins","year":"2005","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD007253.pub2-BIB10|cit10","first-page":"226S","article-title":"Smoking cessation in schizophrenia: A double blind placebo controlled trial of bupropion SR added to cognitive behavioral therapy","volume":"55","author":"Evins","year":"2004","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD007253.pub2-BIB11|cit11","series-title":"Conference abstract of Society for Research on Nicotine and Tobacco 9th Annual Meeting: New Orleans, Louisiana, USA","article-title":"A placebo controlled trial of bupropion SR for smoking cessation in schizophrenia (POS3-49)","author":"Evins","year":"2003"},{"key":"10.1002\/14651858.CD007253.pub2-BIB12|cit12","series-title":"Conference abstract of 156th Annual Meeting of the American Psychiatric Association: San Francisco, USA","article-title":"A controlled trial of bupropion SR for smoking cessation in patients with schizophrenia","author":"Evins","year":"2003"},{"issue":"4","key":"10.1002\/14651858.CD007253.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/01.jcp.0b013e3180ca86fa","article-title":"A 12-week double-blind, placebo-controlled study of bupropion SR added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia","volume":"27","author":"Evins","year":"2007","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD007253.pub2-BIB14|cit14","series-title":"Conference abstract of Society for Research on Nicotine and Tobacco 12th Annual Meeting: Orlando, Florida, USA","article-title":"A placebo-controlled study of bupropion SR added to high dose nicotine replacement therapy for smoking cessation or reduction in schizophrenia (POS2-104)","author":"Evins","year":"2006"},{"key":"10.1002\/14651858.CD007253.pub2-BIB16|cit15","series-title":"Conference abstract of Society for Research on Nicotine and Tobacco 12th Annual Meeting: Orlando, Florida, USA","article-title":"Smoking cessation in persons with schizophrenia and other serious mental illness (PA1-5)","author":"Gallagher","year":"2006"},{"issue":"4","key":"10.1002\/14651858.CD007253.pub2-BIB15|cit16","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/02791072.2007.10399888","article-title":"A comparison of smoking cessation treatments for persons with schizophrenia and other serious mental illnesses","volume":"39","author":"Gallagher","year":"2007","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1002\/14651858.CD007253.pub2-BIB17|cit17","first-page":"S103","article-title":"Predictors of smoking cessation in schizophrenia: Analysis of data from three sequential controlled clinical trials","volume":"29 Suppl 1","author":"George","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD007253.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1176\/appi.ajp.157.11.1835","article-title":"Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia","volume":"157","author":"George","year":"2000","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007253.pub2-BIB19|cit19","series-title":"Conference abstract of the Society for Research on Nicotine and Tobacco 10th Annual Meeting: Phoenix, Arizona, USA","article-title":"Predictors of smoking cessation in schizophrenia: analysis of data from three sequential controlled clinical trials (PA5-3)","author":"Sacco","year":"2004"},{"key":"10.1002\/14651858.CD007253.pub2-BIB20|cit20","first-page":"S103","article-title":"Predictors of smoking cessation in schizophrenia: Analysis of data from three sequential controlled clinical trials","volume":"29 Suppl 1","author":"George","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD007253.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0006-3223(02)01339-2","article-title":"A placebo controlled trial of bupropion for smoking cessation in schizophrenia","volume":"52","author":"George","year":"2002","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD007253.pub2-BIB22|cit22","series-title":"Conference abstract of the Society for Research on Nicotine and Tobacco 10th Annual Meeting: Phoenix, Arizona, USA","article-title":"Predictors of smoking cessation in schizophrenia: analysis of data from three sequential controlled clinical trials (PA5-3)","author":"Sacco","year":"2004"},{"key":"10.1002\/14651858.CD007253.pub2-BIB23|cit23","series-title":"Conference abstract of the College on Problems of Drug Dependence 64th Anuual Scientific Meeting: Quebec, Canada","article-title":"Bupropion versus placebo for smoking cessation in schizophrenia","author":"Vessicchio","year":"2002"},{"key":"10.1002\/14651858.CD007253.pub2-BIB24|cit24","first-page":"S103","article-title":"Predictors of smoking cessation in schizophrenia: Analysis of data from three sequential controlled clinical trials","volume":"29 Suppl. 1","author":"George","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD007253.pub2-BIB25|cit25","first-page":"S254","article-title":"A randomized, double-blind, placebo-controlled trial of sustained-release bupropion combined with transdermal nicotine patch for smoking cessation in schizophrenia: Neuropsychological predictors of treatment outcome","volume":"31 Suppl. 1","author":"George","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD007253.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.biopsych.2007.11.002","article-title":"A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia","volume":"63","author":"George","year":"2008","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD007253.pub2-BIB27|cit27","series-title":"Conference abstract of the Society for Research on Nicotine and Tobacco 13th Annual Meeting: Austin, Texas, USA","article-title":"Sustained-release bupropion combined with transdermal nicotine patch for smoking cessation in schizophrenia (SYM11C)","author":"George","year":"2007"},{"key":"10.1002\/14651858.CD007253.pub2-BIB28|cit28","series-title":"Conference abstract of the Society for Research on Nicotine and Tobacco 10th Annual Meeting: Phoenix, Arizona, USA","article-title":"Predictors of smoking cessation in schizophrenia: analysis of data from three sequential controlled clinical trials (PA5-3)","author":"Sacco","year":"2004"},{"issue":"3","key":"10.1002\/14651858.CD007253.pub2-BIB29|cit29","first-page":"231","article-title":"An efficacy analysis of bupropion for smoking cessation in schizophrenia","volume":"28","author":"Li","year":"2009","journal-title":"Zhongguo Xinyao yu Linchuang Zazhi"},{"key":"10.1002\/14651858.CD007253.pub2-BIB30|cit30","series-title":"Conference abstract of the International Congress on Schizophrenia Research: Colorado Springs, Colorado, USA","article-title":"A comparison of Bupropion SR and Placebo for Smoking Cessation","author":"Weiner","year":"2007"},{"key":"10.1002\/14651858.CD007253.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0920-9964(03)80234-7","article-title":"A comparison of bupropion SR and placebo for smoking cessation in schizophrenia","volume":"60","author":"Weiner","year":"2003","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD007253.pub2-BIB32|cit32","series-title":"Conference abstract of the Society for Research on Nicotine and Tobacco 13th Annual Meeting: Austin, Texas, USA","article-title":"No advantage for high dose compared to regular dose nicotine patch on short-term abstinence rates in schizophrenia (PA2-3)","author":"Williams","year":"2007"},{"key":"10.1002\/14651858.CD007253.pub2-BIB33|cit33","series-title":"Conference abstract from the 150th Annual Meeting of the American Psychiatric Association: San Diego, California, USA","article-title":"Nicotine Withdrawal and Replacement in Schizophrenia","author":"Dalack","year":"1997"},{"key":"10.1002\/14651858.CD007253.pub2-BIB34|cit34","series-title":"Schizophrenia Research (conference abstract from the 6th International Congress on Schizophrenia Research, Colorado Springs, Colorado, USA)","first-page":"63","article-title":"The effects of treated and untreated nicotine withdrawal on smokers with schizophrenia","author":"Dalack","year":"1997"},{"key":"10.1002\/14651858.CD007253.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0893-133X(98)00121-3","article-title":"Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia","volume":"21","author":"Dalack","year":"1999","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD007253.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/14622299050011151","article-title":"Acute feasibility and safety of a smoking reduction strategy for smokers with schizophrenia","volume":"1","author":"Dalack","year":"1999","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1002\/14651858.CD007253.pub2-BIB37|cit37","series-title":"Conference abstract from the 150th Annual Meeting of the American Psychiatric Association: San Diego, California, USA","article-title":"The Nicotine Patch, Smoking and Schizophrenia","author":"Dalack","year":"1997"},{"issue":"2-3","key":"10.1002\/14651858.CD007253.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.schres.2005.02.021","article-title":"A double-blind placebo-controlled cross over trial of bupropion in smoking reduction in schizophrenia [Letter to the Editor]","volume":"76","author":"Fatemi","year":"2005","journal-title":"Schizophrenia Research"},{"issue":"3","key":"10.1002\/14651858.CD007253.pub2-BIB39|cit39","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1176\/ajp.148.3.374","article-title":"Transdermal nicotine and smoking behavior in psychiatric patients","volume":"148","author":"Hartman","year":"1991","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007253.pub2-BIB41|cit40","unstructured":"Steinberg ML Engaging smokers with schizophrenia in treatment for tobacco dependence: A brief motivational interviewing intervention Dissertation Abstracts International: Section B: The Sciences and Engineering 2003 1508"},{"issue":"4","key":"10.1002\/14651858.CD007253.pub2-BIB40|cit41","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1037\/0022-006X.72.4.723","article-title":"Motivational interviewing with personalized feedback: a brief intervention for motivating smokers with schizophrenia to seek treatment for tobacco dependence","volume":"72","author":"Steinberg","year":"2004","journal-title":"Journal of Consulting & Clinical Psychology"},{"issue":"4","key":"10.1002\/14651858.CD007253.pub2-BIB42|cit42","first-page":"349","article-title":"Extended use of nicotine replacement therapy to maintain smoking cessation in persons with schizophrenia","volume":"1","author":"Horst","year":"2005","journal-title":"Neuropsychiatric Disease and Treatment"},{"key":"10.1002\/14651858.CD007253.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1176\/ajp.156.11.1744","article-title":"Double-blind study of clozapine dose response in chronic schizophrenia","volume":"156","author":"Simpson","year":"1999","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD007253.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.pnpbp.2005.04.031","article-title":"Does clozapine decrease smoking?","volume":"29","author":"Leon","year":"2005","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"10.1002\/14651858.CD007253.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1176\/appi.ajp.2007.07050724","article-title":"Galantamine for the treatment of cognitive impairments in people with schizophrenia","volume":"165","author":"Buchanan","year":"2008","journal-title":"American Journal of Psychiatry"},{"issue":"1-3","key":"10.1002\/14651858.CD007253.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.schres.2008.04.027","article-title":"Lack of beneficial galantamine effect for smoking behavior: a double-blind randomized trial in people with schizophrenia","volume":"103","author":"Kelly","year":"2008","journal-title":"Schizophrenia Research"},{"issue":"8","key":"10.1002\/14651858.CD007253.pub2-BIB47|cit47","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/0006-3223(94)00365-A","article-title":"Clozapine decreases smoking in patients with chronic schizophrenia","volume":"37","author":"McEvoy","year":"1995","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD007253.pub2-BIB48|cit48","doi-asserted-by":"crossref","unstructured":"Sacco K A Creeden C Reutenauer E L Vessicchio J C Weinberger A H George T P Effects of atomoxetine on cognitive function and cigarette smoking in schizophrenia Schizophrenia Research 2009 332 3","DOI":"10.1016\/j.schres.2008.09.026"},{"issue":"6","key":"10.1002\/14651858.CD007253.pub2-BIB49|cit49","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1399-5618.2007.00506.x","article-title":"A placebo-controlled, random-assignment, parallel-group pilot study of adjunctive topiramate for patients with schizoaffective disorder, bipolar type","volume":"9","author":"Chengappa","year":"2007","journal-title":"Bipolar Disorder"},{"issue":"2","key":"10.1002\/14651858.CD007253.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/JCP.0b013e31816740cf","article-title":"Effects of topiramate on smoking in patients with schizoaffective disorder, bipolar type","volume":"28","author":"Weinberger","year":"2008","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD007253.pub2-BIB51|cit51","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/JCP.0b013e31819c57d4","article-title":"Effects of topiramate on smoking patients with schizoaffective disorder, bipolar type: Response to Khazaal and Zullino","volume":"29","author":"Weinberger","year":"2009","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD007253.pub2-BIB52|cit52","doi-asserted-by":"crossref","first-page":"iv3","DOI":"10.1136\/tc.12.suppl_4.iv3","article-title":"Effects of motivational interviewing on smoking cessation in adolescents with psychiatric disorders","volume":"12 Suppl 4","author":"Brown","year":"2003","journal-title":"Tobacco Control"},{"key":"10.1002\/14651858.CD007253.pub2-BIB53|cit53","first-page":"141","article-title":"A Group Intervention which assists patients with dual diagnosis reduce their tobacco use","volume-title":"Trends in psychotherapy research","author":"Kisely","year":"2006"},{"key":"10.1002\/14651858.CD007253.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0006-3223(98)00377-1","article-title":"Smoking and therapeutic response to clozapine in patients with schizophrenia","volume":"46","author":"McEvoy","year":"1999","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD007253.pub2-BIB55|cit55","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.schres.2009.07.019","article-title":"Effects of the nicotinic receptor antagonist mecamylamine on ad-lib smoking behaviour, topography, and nicotine levels in smokers with and without schizophrenia: a preliminary study","volume":"115","author":"McKee","year":"2009","journal-title":"Schizophrenia Research"},{"issue":"2","key":"10.1002\/14651858.CD007253.pub2-BIB56|cit56","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1037\/1064-1297.6.2.157","article-title":"Use of monetary reinforcement to reduce the cigarette smoking of persons with schizophrenia: a feasibility study","volume":"6","author":"Roll","year":"1998","journal-title":"Experimental & Clinical Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD007253.pub2-BIB57|cit57","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1037\/1064-1297.10.3.241","article-title":"Contingent monetary reinforcement of smoking reductions, with and without transdermal nicotine, in outpatients with schizophrenia","volume":"10","author":"Tidey","year":"2002","journal-title":"Experimental & Clinical Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD007253.pub2-BIB58|cit58","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1176\/appi.ajp.158.4.635","article-title":"Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophrenia","volume":"158","author":"Weiner","year":"2001","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007253.pub2-BIB59|cit59","unstructured":"Wells ME Increasing motivation to stop smoking among persons with schizophrenia and other chronic mental illnesses Dissertation Abstracts International: Section B: The Sciences and Engineering 2003"},{"issue":"8 Suppl","key":"10.1002\/14651858.CD007253.pub2-BIB60|cit60","first-page":"A309","article-title":"The impact of smoking cessation programs on schizophrenic patients' smoking behaviors [abstract]","volume":"165","author":"Chen","year":"2002","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"5","key":"10.1002\/14651858.CD007253.pub2-BIB61|cit61","first-page":"215","article-title":"The impact of smoking cessation programs on smoking-related health belief and rate of quit-smoking among schizophrenic patients","volume":"22","author":"Chen","year":"2002","journal-title":"Journal of Medical Sciences"},{"issue":"3","key":"10.1002\/14651858.CD007253.pub2-BIB62|cit62","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ijnurstu.2003.07.001","article-title":"The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia","volume":"41","author":"Chou","year":"2004","journal-title":"International Journal of Nursing Studies"},{"key":"10.1002\/14651858.CD007253.pub2-BIB63|cit63","unstructured":"Baker A Healthy lifestyle intervention for cardiovascular disease risk reduction among smokers with psychotic disorders www.anzctr.org.au\/trial_view.aspx?ID=308232 (accessed on 11\/4\/2010)"},{"key":"10.1002\/14651858.CD007253.pub2-BIB64|cit64","unstructured":"Evins AE A study of Varenicline for Prevention of Relapse to Smoking in Patients with Schizophrenia (SCRP) www.clinicaltrials.gov\/ct2\/show\/NCT00621777"},{"key":"10.1002\/14651858.CD007253.pub2-BIB65|cit65","unstructured":"George T rTMS Effects on Smoking Cessation and Cognition in Schizophrenia www.clinicaltrials.gov\/ct2\/show\/NCT00736710"},{"key":"10.1002\/14651858.CD007253.pub2-BIB66|cit66","unstructured":"Josiassen RJ Quetiapine Decreases Smoking in Patients With Chronic Schizophrenia www.clinicaltrials.gov\/ct2\/show\/NCT00231101"},{"key":"10.1002\/14651858.CD007253.pub2-BIB67|cit67","unstructured":"Kosten T Effectiveness of Tropisetron Plus Risperidone for Improving Cognitive and Perceptual Disturbances in Schizophrenia www.clinicaltrials.gov\/ct2\/show\/NCT00435370"},{"key":"10.1002\/14651858.CD007253.pub2-BIB68|cit68","unstructured":"Meszaros ZS Varenicline Treatment in Alcohol and Nicotine Dependent Patients With Schizophrenia www.clinicaltrials.gov\/ct2\/show\/NCT00727103"},{"key":"10.1002\/14651858.CD007253.pub2-BIB69|cit69","unstructured":"Pfizer Smoking Cessation Study for Patients With Schizophrenia or Schizoaffective Disorder www.clinicaltrials.gov\/ct2\/show\/NCT00644969"},{"key":"10.1002\/14651858.CD007253.pub2-BIB70|cit70","unstructured":"Saxon AJ Contingency Management for Smoking Cessation Among Veterans With Psychotic Disorders www.clinicaltrials.gov\/ct2\/show\/NCT00508560"},{"key":"10.1002\/14651858.CD007253.pub2-BIB71|cit71","unstructured":"Smith RC Varenicline for Cigarette Smoking in Schizophrenia - Efficacy and Predictors www.clinicaltrials.gov\/ct2\/show\/NCT00802919"},{"key":"10.1002\/14651858.CD007253.pub2-BIB72|cit72","unstructured":"Tidey JW Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia www.clinicaltrials.gov\/ct2\/show\/NCT00136760"},{"key":"10.1002\/14651858.CD007253.pub2-BIB73|cit73","unstructured":"Weiner E Comparison of Varenicline and Placebo for Smoking Cessation in Schizophrenia www.clinicaltrials.gov\/ct2\/show\/NCT00554840"},{"key":"10.1002\/14651858.CD007253.pub2-BIB74|cit74","unstructured":"Trial of Nicotine Nasal Spray as an Aid for Smoking Cessation in Schizophrenia http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01010477 (accessed on 11\/4\/2010)"},{"issue":"3\/4","key":"10.1002\/14651858.CD007253.pub2-BIB75|cit75","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1300\/J374v03n03_08","article-title":"Psychosocial Treatments for Individuals with Schizophrenia and Tobacco Dependence","volume":"3","author":"Steinberg","year":"2007","journal-title":"Journal of Dual Diagnosis"},{"key":"10.1002\/14651858.CD007253.pub2-BIB76|cit76","series-title":"Conference abstract of the 13th World Conference on Tobacco OR Health: Washington DC, USA","article-title":"Behavioral Therapy Development for Smokers with Schizophrenia","author":"Ziedonis","year":"2006"},{"issue":"2","key":"10.1002\/14651858.CD007253.pub2-BIB77|cit77","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/oxfordjournals.schbul.a033320","article-title":"Schizophrenia, sensory gating, and nicotinic receptors","volume":"24","author":"Adler","year":"1998","journal-title":"Schizophrenia Bulletin"},{"key":"10.1002\/14651858.CD007253.pub2-BIB78|cit78","volume-title":"Diagnostic and Statistical Manual of Mental Disorder","year":"1994"},{"key":"10.1002\/14651858.CD007253.pub2-BIB79|cit79","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1192\/bjp.177.3.212","article-title":"Causes of the excess mortality of schizophrenia","volume":"177","author":"Brown","year":"2000","journal-title":"British Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD007253.pub2-BIB80|cit80","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/schbul\/sbp116","article-title":"The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements","volume":"36","author":"Buchanan","year":"2010","journal-title":"Schizophrenia Bulletin"},{"issue":"3","key":"10.1002\/14651858.CD007253.pub2-BIB81|cit81","article-title":"Competitions and incentives for smoking cessation","author":"Cahill","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7406","key":"10.1002\/14651858.CD007253.pub2-BIB82|cit82","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/bmj.327.7406.65","article-title":"Balancing benefits and harms in health care","volume":"327","author":"Cuervo","year":"2003","journal-title":"British Medical Journal"},{"issue":"11","key":"10.1002\/14651858.CD007253.pub2-BIB83|cit83","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.4088\/JCP.v69n1109","article-title":"Predictors of early abstinence in smokers with schizophrenia","volume":"69","author":"Culhane","year":"2008","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2\/3","key":"10.1002\/14651858.CD007253.pub2-BIB84|cit84","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.schres.2005.02.010","article-title":"A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors","volume":"76","author":"Leon","year":"2005","journal-title":"Schizophrenia Research"},{"issue":"6","key":"10.1002\/14651858.CD007253.pub2-BIB85|cit85","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2165\/00023210-200115060-00005","article-title":"Smoking in patients receiving psychotropic medications: A pharmacokinetic perspective","volume":"15","author":"Desai","year":"2001","journal-title":"CNS Drugs"},{"key":"10.1002\/14651858.CD007253.pub2-BIB86|cit86","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/S0920-9964(98)00161-3","article-title":"Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes","volume":"35 Suppl","author":"Dixon","year":"1999","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD007253.pub2-BIB87|cit87","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890423929","volume-title":"Guideline Watch (September 2009): Practice Guideline for the Treatment of Patients with Schizophrenia","author":"Dixon","year":"2009"},{"key":"10.1002\/14651858.CD007253.pub2-BIB88|cit88","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0006-3223(85)90063-0","article-title":"Effects of smoking on fluphenazine clearance in psychiatric inpatients","volume":"20","author":"Ereshefsky","year":"1985","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD007253.pub2-BIB89|cit89","volume-title":"Treating tobacco use and dependence: 2008 Update - Clinical Practice Guideline","author":"Fiore","year":"2008"},{"key":"10.1002\/14651858.CD007253.pub2-BIB90|cit90","doi-asserted-by":"crossref","first-page":"7326","DOI":"10.1038\/sj.onc.1205808","article-title":"Epidemiology of tobacco use in the United States","volume":"21","author":"Giovino","year":"2002","journal-title":"Oncogene"},{"key":"10.1002\/14651858.CD007253.pub2-BIB91|cit91","unstructured":"Prescribing Information (Wellbutrin XL - bupropion hydrochloride extended-release tablets) http:\/\/us.gsk.com\/products\/assets\/us_wellbutrinXL.pdf 2008"},{"issue":"9","key":"10.1002\/14651858.CD007253.pub2-BIB92|cit92","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1176\/ajp.149.9.1189","article-title":"Cigarette smoking in schizophrenia: Relaitonship to psychopathology and medication side effects","volume":"149","author":"Goff","year":"1992","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD007253.pub2-BIB93|cit93","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2466\/pr0.1992.70.2.603","article-title":"Operant conditioning of activities of daily living on a psychogeriatric ward: A simple method","volume":"70","author":"Gustafson","year":"1992","journal-title":"Psychological Reports"},{"key":"10.1002\/14651858.CD007253.pub2-BIB94|cit94","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"7414","author":"Higgins","year":"2003","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD007253.pub2-BIB95|cit95","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S [eds] Cochrane Handbook for Systematic Reviews of Interventions,5.0.0 [updated February 2008] 2008","DOI":"10.1002\/9780470712184"},{"key":"10.1002\/14651858.CD007253.pub2-BIB96|cit96","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/j.1360-0443.2005.01174.x","article-title":"The feasibility of smoking reduction: an update","volume":"100","author":"Hughes","year":"2005","journal-title":"Addiction"},{"issue":"6","key":"10.1002\/14651858.CD007253.pub2-BIB97|cit97","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1080\/14622200600789726","article-title":"Does smoking reduction increase future cessation and decrease disease risk? A qualitative review","volume":"8","author":"Hughes","year":"2006","journal-title":"Nicotine & Tobacco Research"},{"issue":"1","key":"10.1002\/14651858.CD007253.pub2-BIB98|cit98","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000031.pub3","article-title":"Antidepressants for smoking cessation","author":"Hughes","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007253.pub2-BIB99|cit99","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2165\/00023210-200519100-00005","article-title":"Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function","volume":"19","author":"Johnson","year":"2005","journal-title":"CNS Drugs"},{"issue":"11","key":"10.1002\/14651858.CD007253.pub2-BIB100|cit100","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1176\/ajp.156.11.1751","article-title":"Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland","volume":"156","author":"Kelly","year":"1999","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD007253.pub2-BIB101|cit101","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/schbul\/sbp130","article-title":"The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2009","volume":"36","author":"Kreyenbuhl","year":"2010","journal-title":"Schizophrenia Bulletin"},{"issue":"2","key":"10.1002\/14651858.CD007253.pub2-BIB102|cit102","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00213-002-1099-x","article-title":"Effects of typical and atypical antipsychotics on prepulse inhibition in schizophrenia: A critical evaluation of current evidence and directions for future research","volume":"162","author":"Kumari","year":"2002","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD007253.pub2-BIB103|cit103","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001292.pub2","article-title":"Individual behavioural counselling for smoking cessation","author":"Lancaster","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD007253.pub2-BIB104|cit104","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001118.pub2","article-title":"Self-help interventions for smoking cessation","author":"Lancaster","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD007253.pub2-BIB105|cit105","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1080\/j.1440-1614.2005.01697.x","article-title":"Smoking bans in psychiatric inpatient settings? A review of the research","volume":"39","author":"Lawn","year":"2005","journal-title":"The Australian & New Zeland Journal of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD007253.pub2-BIB106|cit106","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/archpsyc.58.6.573","article-title":"Incidence of cancer among persons with schizophrenia and their relatives","volume":"58","author":"Lichtermann","year":"2001","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD007253.pub2-BIB107|cit107","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/BF02246063","article-title":"Haloperidol increases smoking inpatients with schizophrenia","volume":"119","author":"McEvoy","year":"1995","journal-title":"Psychopharmacology"},{"issue":"1-2","key":"10.1002\/14651858.CD007253.pub2-BIB108|cit108","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.drugalcdep.2009.04.005","article-title":"Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia","volume":"104","author":"Moss","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1002\/14651858.CD007253.pub2-BIB109|cit109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-3223(96)00302-2","article-title":"Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers","volume":"42","author":"Olincy","year":"1997","journal-title":"Biological Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD007253.pub2-BIB110|cit110","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/0269881104047273","article-title":"Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders","volume":"18","author":"Sacco","year":"2004","journal-title":"Journal of Psychopharmacology"},{"key":"10.1002\/14651858.CD007253.pub2-BIB111|cit111","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0376-8716(99)00162-3","article-title":"Current models of nicotine dependence: What is known and what is needed to advance understanding of tobacco etiology among youth","volume":"59 Suppl 1","author":"Shadel","year":"2000","journal-title":"Drug and Alcohol Dependence"},{"issue":"5","key":"10.1002\/14651858.CD007253.pub2-BIB112|cit112","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1080\/14622200802027198","article-title":"Changes in psychiatric patients' thoughts about quitting smoking during a smoke-free hospitalization","volume":"10","author":"Shmueli","year":"2008","journal-title":"Nicotine & Tobacco Research"},{"issue":"2","key":"10.1002\/14651858.CD007253.pub2-BIB113|cit113","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001007.pub2","article-title":"Group behaviour therapy programmes for smoking cessation","author":"Stead","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD007253.pub2-BIB114|cit114","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002850.pub2","article-title":"Telephone counselling for smoking cessation","author":"Stead","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD007253.pub2-BIB115|cit115","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000165.pub3","article-title":"Physician advice for smoking cessation","author":"Stead","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD007253.pub2-BIB116|cit116","first-page":"206","article-title":"Financial implications of cigarette smoking among individuals with schizophrenia","volume":"13","author":"Steinberg","year":"2004","journal-title":"Tobacco Control"},{"key":"10.1002\/14651858.CD007253.pub2-BIB117|cit117","article-title":"Smoking Reduction and Cessation for People with Schizophrenia: Guidelines for General Practitioners","volume-title":"Smoking Reduction and Cessation for People with Schizophrenia:Guidelines for General Practitioners","author":"Strasser","year":"2001"},{"issue":"12","key":"10.1002\/14651858.CD007253.pub2-BIB118|cit118","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.290.12.1624","article-title":"Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy","volume":"290","author":"Tunis","year":"2003","journal-title":"Journal of American Medical Association"},{"key":"10.1002\/14651858.CD007253.pub2-BIB119|cit119","volume-title":"Reducing Tobacco Use. A Report of the US Surgeon General","year":"2000"},{"issue":"3","key":"10.1002\/14651858.CD007253.pub2-BIB120|cit120","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1360-0443.2004.00995.x","article-title":"Outcome criteria in smoking cessation trials: proposal for a common standard","volume":"100","author":"West","year":"2005","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD007253.pub2-BIB121|cit121","unstructured":"West R Background smoking cessation rates in England www.smokinginengland.info\/Ref\/paper2.pdf 2006"},{"issue":"2-3","key":"10.1002\/14651858.CD007253.pub2-BIB122|cit122","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.schres.2005.04.016","article-title":"Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect","volume":"79","author":"Williams","year":"2005","journal-title":"Schizophrenia Research"},{"issue":"5","key":"10.1002\/14651858.CD007253.pub2-BIB123|cit123","first-page":"27","article-title":"Snuffing out tobacco dependence. Ten reasons behavioral health providers need to be involved","volume":"26","author":"Williams","year":"2006","journal-title":"Behavioral Healthcare"},{"key":"10.1002\/14651858.CD007253.pub2-BIB124|cit124","volume-title":"Practice Guideline for the Treatment of Patients With Substance Use Disorders","year":"2006"},{"key":"10.1002\/14651858.CD007253.pub2-BIB125|cit125","volume-title":"International Classification of Diseases","year":"2003"},{"issue":"1","key":"10.1002\/14651858.CD007253.pub2-BIB126|cit126","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1176\/ps.2009.60.1.100","article-title":"Smoking restrictions and treatment for smoking: policies and procedures in psychiatric inpatient units in Australia","volume":"60","author":"Wye","year":"2009","journal-title":"Psychiatric Service"},{"key":"10.1002\/14651858.CD007253.pub2-BIB127|cit127","first-page":"204","article-title":"Nicotine dependence and schizophrenia","volume":"45(3)","author":"Ziedonis","year":"1994","journal-title":"Hospital and Community Psychiatry"},{"issue":"3\/4","key":"10.1002\/14651858.CD007253.pub2-BIB128|cit128","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1300\/J374v03n03_10","article-title":"Program and System Level Interventions to Address Tobacco Amongst Individuals with Schizophrenia","volume":"3","author":"Ziedonis","year":"2007","journal-title":"Journal of Dual Diagnosis"},{"key":"10.1002\/14651858.CD007253.pub2-BIB129|cit129","volume-title":"Smoking cessation pharmacotherapy: an update for health professionals","author":"Zwar","year":"2007"},{"key":"10.1002\/14651858.CD007253.pub2-BIB130|cit130","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1192\/bjp.bp.109.066019","article-title":"Efficacy and safety of bupropion for smoking cessation and reduction in schizophrenia: systematic review and meta-analysis","volume":"196","author":"Tsoi","year":"2010","journal-title":"British Journal of Psychiatry"}],"updated-by":[{"DOI":"10.1002\/14651858.cd007253.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,2,28]],"date-time":"2013-02-28T00:00:00Z","timestamp":1362009600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD007253.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:06:20Z","timestamp":1740164780000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD007253.pub2"}},"subtitle":[],"editor":[{"given":"Daniel T","family":"Tsoi","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2010,6,15]]},"references-count":130,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007253.pub2","relation":{},"subject":[],"published":{"date-parts":[[2010,6,15]]}}}